Pfizer's strategic weaknesses mount and the stock became overvalued after the recent rally. Read more to see our analysis on ...

Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

AM Best has confirmed the financial strength rating of A (Excellent) and the long-term issuer credit rating of a+ (Excellent) ...

As BioNTech continues to endure a sharp decline in COVID-19 vaccine sales, the German mRNA specialist is looking ahead to the ...

There’s long been a global shortage of the BCG vaccine for bladder cancer. But since ImmunityBio won FDA approval for Anktiva ...

Pfizer, a leading American pharmaceutical company, is redirecting its attention towards the cancer treatment market following ...

By Colin Kellaher Pfizer had hired Andrew Baum as the drugmaker's next chief strategy and innovation officer. Pfizer on Monday said Baum, who has been ...

Biopharma giant Pfizer Inc. (NYSE: PFE) has given back all its COVID gains and more. Shareholders have sat through a painful ...

Germany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday ...

About 31 percent of women who reported migraines in a national health survey said they experienced them during menstruation, ...

Pfizer has tapped Wall Street analyst Andrew Baum to be its new chief strategy and innovation officer, where he'll head up ...